about
China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2015 version)Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancersHeterogeneity of epidermal growth factor receptor mutations in lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements: A case report.Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysisCytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis.Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.Allogeneic cell-based immunotherapy combined with chemotherapy and targeted therapy in advanced pancreatic cancer with metastases: A case report.The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC.Activating transcription factor 3 promotes colon cancer metastasis.ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549.Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study.The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population.Effects of targeted silencing of FOXC1 gene on proliferation and in vitro migration of human non-small-cell lung carcinoma cells.Adoptive immunotherapy for small cell lung cancer by expanded activated autologous lymphocytes: a retrospective clinical analysis.[FHL1 knockdown mediated by lentiviral shRNA promotes the growth of HeLa and HepG2 cells].The role of miR-485-5p/NUDT1 axis in gastric cancer.Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia.Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation.[Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma].Circulating and tumor-infiltrating myeloid-derived suppressor cells in cervical carcinoma patients.[The expression of fibroblast activation protein-α in primary breast cancer is associated with poor prognosis]
P50
Q26800148-686AD8A4-A605-4C1D-930B-014317E4BECFQ34000141-2AAF0BCC-0CE0-4487-8941-BB7B7036AA0EQ34247227-B4356ED3-9812-4D7A-89EE-E67A78BB41E2Q34293223-F7C4C63E-BBCF-4828-8C80-840F1D55E7EFQ35173555-1FFD1182-404A-423D-BFEB-8542FD321AA3Q35783412-A8C34517-B658-402F-ABD5-736919473E5DQ36464730-40F5D534-BA4E-4153-9D79-03BE87CDE056Q37719986-590A44A2-8512-4C69-9D1C-9AC9916673EAQ38878715-D369D72F-EE74-4517-B535-878FCD4D902DQ38991694-A818C318-08F5-459A-8EAF-E222264125ABQ39090738-C732DCE7-A2F7-4421-A5EA-4EC6457913D1Q39412383-662E42B7-6843-4230-A588-74C2C943B39DQ39507138-B535E91F-2750-4B9D-9AC9-E0C8ADA3D737Q41003401-AB07AA7A-F893-4A07-9A7C-F6AB7C108A6BQ41286369-E5FDB0E2-EC5F-480E-87B8-60A4383EC474Q41610967-A6141838-BD23-4DA8-96D4-0693C86C2972Q42682612-DEC840F6-4197-46E9-9CA8-367CDDA9BB69Q45947877-5656E091-8CC6-477D-B0D2-25827FE88B5AQ48746201-9C46544D-60FF-4BCC-9F47-27BC860EC7FCQ53454916-18318932-3C31-4CCC-B673-B49044B9E7D1Q54965346-0A008B1B-14CA-45B2-803F-07D334F67A27Q56896226-130BCA78-0632-49FB-84B4-57DD0D48CF7D
P50
name
Shunchang Jiao
@en
type
label
Shunchang Jiao
@en
prefLabel
Shunchang Jiao
@en
P31
P496
0000-0001-9184-082X